NASDAQ:QTNT

Quotient Stock Forecast, Price & News

$3.40
-0.01 (-0.29 %)
(As of 08/2/2021 11:06 AM ET)
Add
Compare
Today's Range
$3.34
$3.40
50-Day Range
$3.05
$4.42
52-Week Range
$2.98
$8.39
Volume1,600 shs
Average Volume659,433 shs
Market Capitalization$345.19 million
P/E RatioN/A
Dividend YieldN/A
Beta2.32
30 days | 90 days | 365 days | Advanced Chart
Receive QTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for Quotient and its competitors with MarketBeat's FREE daily newsletter.


Quotient logo

About Quotient

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ COVID-19 Microarray that is designed as a serological disease screening microarray specific to COVID-19 antibody detection. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.99 out of 5 stars

Medical Sector

400th out of 2,221 stocks

Diagnostic Substances Industry

4th out of 38 stocks

Analyst Opinion: 3.3Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Quotient (NASDAQ:QTNT) Frequently Asked Questions

Is Quotient a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Quotient in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Quotient stock.
View analyst ratings for Quotient
or view top-rated stocks.

What stocks does MarketBeat like better than Quotient?

Wall Street analysts have given Quotient a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Quotient wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Quotient's next earnings date?

Quotient is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Quotient
.

How can I listen to Quotient's earnings call?

Quotient will be holding an earnings conference call on Thursday, August 5th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "4861155".

How were Quotient's earnings last quarter?

Quotient Limited (NASDAQ:QTNT) posted its earnings results on Monday, May, 31st. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.13. The company earned $9.64 million during the quarter, compared to the consensus estimate of $8.90 million. Quotient had a negative trailing twelve-month return on equity of 6,699.81% and a negative net margin of 250.05%.
View Quotient's earnings history
.

How has Quotient's stock been impacted by Coronavirus (COVID-19)?

Quotient's stock was trading at $4.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, QTNT stock has decreased by 26.7% and is now trading at $3.40.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for QTNT?

2 Wall Street analysts have issued 1-year target prices for Quotient's stock. Their forecasts range from $5.00 to $13.50. On average, they anticipate Quotient's stock price to reach $9.25 in the next year. This suggests a possible upside of 172.1% from the stock's current price.
View analysts' price targets for Quotient
or view top-rated stocks among Wall Street analysts.

Who are Quotient's key executives?

Quotient's management team includes the following people:
  • Mr. Peter Buhler, Chief Financial Officer (Age 51, Pay $400.99k)
  • Mr. Jeremy Stackawitz, Chief Commercial Officer (Age 46, Pay $655.96k)
  • Mr. Manuel O. Mendez, Chief Exec. Officer (Age 53)
  • Mr. Ernest Larnach, Head of Financial Accounting (Age 51)
  • Dr. Michael Hausmann, Chief Technology Officer
  • Ms. Vittoria Bonasso, Head of Fin. & Group Controller (Age 45)

Who are some of Quotient's key competitors?

What other stocks do shareholders of Quotient own?

What is Quotient's stock symbol?

Quotient trades on the NASDAQ under the ticker symbol "QTNT."

Who are Quotient's major shareholders?

Quotient's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Alliancebernstein L.P. (0.05%). Company insiders that own Quotient stock include Edward Farrell, Jeremy Stackawitz, Perceptive Advisors Llc, Peter Buhler, Prondzynski Heino Von and Roland Boyd.
View institutional ownership trends for Quotient
.

Which major investors are buying Quotient stock?

QTNT stock was acquired by a variety of institutional investors in the last quarter, including Alliancebernstein L.P.. Company insiders that have bought Quotient stock in the last two years include Perceptive Advisors Llc, Peter Buhler, and Prondzynski Heino Von.
View insider buying and selling activity for Quotient
or or view top insider-buying stocks.

How do I buy shares of Quotient?

Shares of QTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quotient's stock price today?

One share of QTNT stock can currently be purchased for approximately $3.40.

How much money does Quotient make?

Quotient has a market capitalization of $345.19 million and generates $43.38 million in revenue each year. The company earns $-108,470,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis.

How many employees does Quotient have?

Quotient employs 435 workers across the globe.

What is Quotient's official website?

The official website for Quotient is www.quotientbd.com.

Where are Quotient's headquarters?

Quotient is headquartered at B1 Business Park Terre Bonne Route de Crassier 13, Eysins Y9, 1262.

How can I contact Quotient?

Quotient's mailing address is B1 Business Park Terre Bonne Route de Crassier 13, Eysins Y9, 1262. The company can be reached via phone at 011-41-22-716-9800 or via email at [email protected]


This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.